Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Leclerc

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2013
Nanoparticle adjuvant sensing by TLR7 enhances CD8+ T cell-mediated protection from Listeria monocytogenes infectionMarie-Ève Lebel, Jean-François Daudelin, Karine Chartrand, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 9, 2018
The quest for a nanoparticle-based vaccine inducing broad protection to influenza virusesMarilène Bolduc, Mariana Baz, Marie-Ève Laliberté-Gagné, et al.
Protein Expression and Purification|May 18, 2023
A rapid procedure to generate stably transfected HEK293 suspension cells for recombinant protein manufacturing: Yield improvements, bioreactor production and downstream processingShantoshini Dash, Omar Farnós, Zeyu Yang, et al.
Plos One|December 31, 2021
MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagyDavid Possamaï, Laïla-Aïcha Hanafi, Angélique Bellemare-Pelletier, et al.
Journal of Nanobiotechnology|July 20, 2017
A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen couplingAriane Thérien, Mikaël Bédard, Damien Carignan, et al.
Virology|June 21, 2005
A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cellsMarie-Eve Paré, Sonia Gauthier, Sébastien Landry, et al.
Vaccine|July 6, 2010
Two distinct chimeric potexviruses share antigenic cross-presentation properties of MHC class I epitopesLaïla-Aïcha Hanafi, Marilène Bolduc, Marie-Eve Laliberté Gagné, et al.
Vaccine|February 14, 2012
Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]Christian Savard, Marie-Ève Laliberté-Gagné, Cindy Babin, et al.
Vaccines|November 7, 2020
Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical EvaluationOmar Farnós, Alina Venereo-Sánchez, Xingge Xu, et al.
The FEBS Journal|December 22, 2005
Effect of mutations K97A and E128A on RNA binding and self assembly of papaya mosaic potexvirus coat proteinMarie-Hélène Tremblay, Nathalie Majeau, Marie-Eve Laliberté Gagné, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2013
Nanoparticle adjuvant sensing by TLR7 enhances CD8+ T cell-mediated protection from Listeria monocytogenes infectionMarie-Ève Lebel, Jean-François Daudelin, Karine Chartrand, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 9, 2018
The quest for a nanoparticle-based vaccine inducing broad protection to influenza virusesMarilène Bolduc, Mariana Baz, Marie-Ève Laliberté-Gagné, et al.
Protein Expression and Purification|May 18, 2023
A rapid procedure to generate stably transfected HEK293 suspension cells for recombinant protein manufacturing: Yield improvements, bioreactor production and downstream processingShantoshini Dash, Omar Farnós, Zeyu Yang, et al.
Plos One|December 31, 2021
MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagyDavid Possamaï, Laïla-Aïcha Hanafi, Angélique Bellemare-Pelletier, et al.
Journal of Nanobiotechnology|July 20, 2017
A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen couplingAriane Thérien, Mikaël Bédard, Damien Carignan, et al.
Virology|June 21, 2005
A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cellsMarie-Eve Paré, Sonia Gauthier, Sébastien Landry, et al.
Vaccine|July 6, 2010
Two distinct chimeric potexviruses share antigenic cross-presentation properties of MHC class I epitopesLaïla-Aïcha Hanafi, Marilène Bolduc, Marie-Eve Laliberté Gagné, et al.
Vaccine|February 14, 2012
Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]Christian Savard, Marie-Ève Laliberté-Gagné, Cindy Babin, et al.
Vaccines|November 7, 2020
Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical EvaluationOmar Farnós, Alina Venereo-Sánchez, Xingge Xu, et al.
The FEBS Journal|December 22, 2005
Effect of mutations K97A and E128A on RNA binding and self assembly of papaya mosaic potexvirus coat proteinMarie-Hélène Tremblay, Nathalie Majeau, Marie-Eve Laliberté Gagné, et al.
Pageof 6